Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis

• Autores principales: Lin L (Autor), Wang W (Autor), Wu Y (Autor), Xie J (Autor), Li X (Autor), Pan X (Autor), Zhang W (Autor), Xu J (Autor), Cai Y (Autor), Ren H (Autor), Chen N (Autor)
• Formato: Libro
• Publicado: Dove Medical Press, 2021-05-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Li Lin,1 Weiming Wang,1 YiFan Wu,2 JingYuan Xie,1 Xiao Li,1 XiaoXia Pan,1 Wen Zhang,1 Jing Xu,1 YiKai Cai,1 Hong Ren,1 Nan Chen1 1Department of Nephrology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of China; 2Biomedical and Health Inform...